Title 958 CMR 12.00 - Drug Pricing Review
- Section 12.01 - Scope and Purpose
- Section 12.02 - Definitions
- Section 12.03 - Notice of Identification by the Executive Office
- Section 12.04 - Standard Reporting Form, Requests for Information, and Attestation Form
- Section 12.05 - Public Notice and Stakeholder Input
- Section 12.06 - Identification of a Proposed Value
- Section 12.07 - Identification of a Proposed Supplemental Rebate
- Section 12.08 - Determination of Potentially Unreasonable or Excessive Pricing
- Section 12.09 - Determination of Unreasonable or Excessive Pricing
- Section 12.10 - Further Negotiations with the Executive Office
- Section 12.11 - Information Provided by the Executive Office in Connection with the Referral
- Section 12.12 - Confidentiality
- Section 12.13 - Penalties
- Section 12.14 - Applicability to Individual Patients
- Section 12.15 - Severability